JP5031585B2 - ５−フルオロ−ウラシル免疫測定法 - Google Patents

５−フルオロ−ウラシル免疫測定法 Download PDF

Info

Publication number
JP5031585B2
JP5031585B2 JP2007554208A JP2007554208A JP5031585B2 JP 5031585 B2 JP5031585 B2 JP 5031585B2 JP 2007554208 A JP2007554208 A JP 2007554208A JP 2007554208 A JP2007554208 A JP 2007554208A JP 5031585 B2 JP5031585 B2 JP 5031585B2
Authority
JP
Japan
Prior art keywords
compound
general formula
antibody
uracil
conjugate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2007554208A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008530528A5 (https=
JP2008530528A (ja
Inventor
サラモネ、サルヴァトーレ
ブレーク コートニー、ジョディ
ストッカー、デニス
Original Assignee
サラダックス バイオメディカル インク．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by サラダックス バイオメディカル インク． filed Critical サラダックス バイオメディカル インク．
Publication of JP2008530528A publication Critical patent/JP2008530528A/ja
Publication of JP2008530528A5 publication Critical patent/JP2008530528A5/ja
Application granted granted Critical
Publication of JP5031585B2 publication Critical patent/JP5031585B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/811—Peptides or proteins is immobilized on, or in, an inorganic carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/13—Tracers or tags

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2007554208A 2005-02-08 2006-02-02 ５−フルオロ−ウラシル免疫測定法 Expired - Lifetime JP5031585B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/053,480 US20060177883A1 (en) 2005-02-08 2005-02-08 5-Fluoro-uracil immunoassay
US11/053,480 2005-02-08
PCT/US2006/003674 WO2006086208A2 (en) 2005-02-08 2006-02-02 5-fluoro-uracil immunoassay

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012115934A Division JP2012197285A (ja) 2005-02-08 2012-05-21 化合物及び共役

Publications (3)

Publication Number Publication Date
JP2008530528A JP2008530528A (ja) 2008-08-07
JP2008530528A5 JP2008530528A5 (https=) 2009-03-26
JP5031585B2 true JP5031585B2 (ja) 2012-09-19

Family

ID=36780436

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007554208A Expired - Lifetime JP5031585B2 (ja) 2005-02-08 2006-02-02 ５−フルオロ−ウラシル免疫測定法
JP2012115934A Pending JP2012197285A (ja) 2005-02-08 2012-05-21 化合物及び共役

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012115934A Pending JP2012197285A (ja) 2005-02-08 2012-05-21 化合物及び共役

Country Status (7)

Country Link
US (4) US20060177883A1 (https=)
EP (4) EP2280280A1 (https=)
JP (2) JP5031585B2 (https=)
CN (1) CN101147063B (https=)
CA (1) CA2597044C (https=)
ES (2) ES2485691T3 (https=)
WO (1) WO2006086208A2 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008103319A2 (en) 2007-02-16 2008-08-28 Ark Diagnostics, Inc. Compounds and methods for use in detecting gabapentin
EP2349335B1 (en) 2008-10-24 2013-08-07 ARK Diagnostics, Inc. Levetiracetam immunoassays
CN102648412A (zh) * 2009-07-17 2012-08-22 美瑞德生物工程公司 5-fu的检测方法
WO2011022174A1 (en) * 2009-08-21 2011-02-24 Myriad Genetics, Inc. Method of processing blood samples containing 5-fu
WO2011109274A1 (en) * 2010-03-01 2011-09-09 Concert Pharmaceuticals Inc. Fluorouracil derivatives
US8426143B2 (en) 2011-05-24 2013-04-23 Saladax Biomedical Inc. Gemcitabine immunoassay
JP2015502356A (ja) * 2011-11-30 2015-01-22 ウェルスタット ダイアグノスティクス，エルエルシー ５−ｆｕに関連するアッセイ、抗体、免疫原および組成物
US9213043B2 (en) 2012-05-15 2015-12-15 Wellstat Diagnostics, Llc Clinical diagnostic system including instrument and cartridge
US9625465B2 (en) 2012-05-15 2017-04-18 Defined Diagnostics, Llc Clinical diagnostic systems
US9081001B2 (en) 2012-05-15 2015-07-14 Wellstat Diagnostics, Llc Diagnostic systems and instruments
JP6352258B2 (ja) 2012-07-16 2018-07-04 センターズ フォー ディジーズ コントロール アンド プリベンション 抗腫瘍薬による表面汚染に対する直接読み取り検出キット
CN104736565B (zh) * 2012-08-21 2019-03-12 詹森药业有限公司 利培酮半抗原的抗体及其用途
EP2945942B1 (en) 2013-01-18 2018-05-09 ARK Diagnostics, Inc. Voriconazole immunoassays
US9920136B2 (en) 2013-02-13 2018-03-20 Ark Diagnostics, Inc. Posaconazole immunoassays
CN104478813A (zh) * 2014-12-20 2015-04-01 苏州博源医疗科技有限公司 5-氟尿嘧啶衍生物、5-氟尿嘧啶免疫原及其抗体与5-氟尿嘧啶检测试剂盒
CN107132347A (zh) * 2016-11-25 2017-09-05 南方医科大学 一种实时监测5‑氟尿嘧啶血药浓度的时间分辨荧光检测试剂盒
US11391748B2 (en) 2017-09-21 2022-07-19 Becton, Dickinson And Company High dynamic range assays in hazardous contaminant testing
WO2019060269A1 (en) 2017-09-21 2019-03-28 Becton, Dickinson And Company KIT FOR COLLECTING HAZARDOUS CONTAMINANTS AND RAPID ANALYSIS
USD859683S1 (en) 2017-09-21 2019-09-10 Becton, Dickinson And Company Collection device
US11002642B2 (en) 2017-09-21 2021-05-11 Becton, Dickinson And Company Demarcation template for hazardous contaminant testing
EP3836971A4 (en) 2018-08-13 2022-06-22 Flagship Pioneering Innovations V, Inc. CONJUGATES AND METHODS OF USE THEREOF
CA3125355A1 (en) 2019-01-28 2020-08-06 Becton, Dickinson And Company Hazardous contaminant collection device with integrated swab and test device
CN110156872B (zh) * 2019-05-27 2020-09-08 山东省医学科学院药物研究所（山东省抗衰老研究中心、山东省新技术制药研究所） 替加氟衍生物及其制备方法和用途
WO2020252053A1 (en) 2019-06-13 2020-12-17 Becton, Dickinson And Company Multiplexed turbidimetric immunoassays to monitor environmental contamination
CN111875587B (zh) * 2020-07-23 2021-07-13 湖南苏阳医疗科技有限公司 5-氟胞嘧啶衍生物、其制备方法及其在5-氟胞嘧啶免疫检测试剂中的应用
CN113501877A (zh) * 2021-08-23 2021-10-15 苏州科铭生物技术有限公司 抗5-氟尿嘧啶单克隆抗体的制备方法、5-氟尿嘧啶的酶联免疫检测方法
CN114907274A (zh) * 2022-05-11 2022-08-16 宁夏医科大学 5-氟尿嘧啶-1-烷基酸衍生物及制备方法及其应用
CN114605338B (zh) * 2022-05-11 2022-10-28 深圳厚存纳米药业有限公司 一种含尿嘧啶衍生物的纳米粒、核酸纳米复合物及其制备方法和用途
CN116183897A (zh) * 2023-02-24 2023-05-30 苏州大学 一种化学发光免疫传感器及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996344A (en) 1972-05-15 1976-12-07 Biological Developments, Inc. Phenethylamine antigenic conjugates, their preparation, antibodies and use
US4016146A (en) 1974-12-10 1977-04-05 Biological Developments, Inc. Phenethylamine antigenic conjugates, their preparation, antibodies, and use
US3996334A (en) * 1975-06-02 1976-12-07 Southwire Company Process for recovering aluminum from alunite
US4269511A (en) 1979-02-15 1981-05-26 Abbott Laboratories Apparatus and method for measuring the magnitude of polarization of light
US4420568A (en) 1980-07-30 1983-12-13 Abbott Laboratories Fluorescent polarization immunoassay utilizing substituted triazinylaminofluoresceins
JPS63222699A (ja) 1987-03-11 1988-09-16 Sendai Biseibutsu Kenkyusho 単クローン性抗体及びこれを用いるシユードウリジンψの測定法
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5101015A (en) 1989-04-10 1992-03-31 Abbott Laboratories Reagents for an amphetamine-class fluorescence polarization immunoassay
CA2096495C (en) 1992-06-16 2002-07-09 Kathy Palmer Ordonez Dual analyte immunoassay
US5789192A (en) 1992-12-10 1998-08-04 Schering Corporation Mammalian receptors for interleukin-10 (IL-10)
JP3479453B2 (ja) 1998-05-28 2003-12-15 大鵬薬品工業株式会社 尿中テガフールの測定法
JP4070372B2 (ja) * 1999-10-19 2008-04-02 有限会社バイオメディカルリサーチグループ 抗ウラシルモノクローナル抗体

Also Published As

Publication number Publication date
CN101147063B (zh) 2014-02-12
US20070154972A1 (en) 2007-07-05
US9551724B2 (en) 2017-01-24
EP2280281A1 (en) 2011-02-02
CA2597044C (en) 2014-05-20
EP2280280A1 (en) 2011-02-02
US20060177884A1 (en) 2006-08-10
US20100204456A1 (en) 2010-08-12
HK1116864A1 (en) 2009-01-02
JP2008530528A (ja) 2008-08-07
US7205116B2 (en) 2007-04-17
HK1147799A1 (en) 2011-08-19
WO2006086208A3 (en) 2007-04-26
US7767794B2 (en) 2010-08-03
EP1846763A2 (en) 2007-10-24
WO2006086208A2 (en) 2006-08-17
ES2400773T3 (es) 2013-04-12
EP2317325A1 (en) 2011-05-04
CN101147063A (zh) 2008-03-19
US20060177883A1 (en) 2006-08-10
EP1846763B1 (en) 2012-12-05
CA2597044A1 (en) 2006-08-17
ES2485691T3 (es) 2014-08-14
JP2012197285A (ja) 2012-10-18
EP2280281B1 (en) 2014-05-21
EP1846763A4 (en) 2008-04-02

Similar Documents

Publication Publication Date Title
JP5031585B2 (ja) ５−フルオロ−ウラシル免疫測定法
US8114621B2 (en) Lenalidomide and thalidomide immunoassays
EP2467139B1 (en) Imatinib immunoassay
JP4889054B2 (ja) ドセタキセル免疫測定方法
JP2010189414A (ja) サイトキサン抗体及びイムノアッセイ
US20060024752A1 (en) Cytoxan antibodies and immunoassay
JP4486994B2 (ja) ブスルファンイムノアッセイ
HK1116864B (en) 5-fluoro-uracil immunoassay
HK1157864A (en) 5-fluoro-uracil immunoassay
HK1147799B (en) 5-fluoro-uracil immunoassay
HK1147800A (en) 5-fluoro-uracil immunoassay

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090202

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090202

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090202

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20110114

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110125

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110422

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110502

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110520

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110527

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110627

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110708

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110725

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110816

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111220

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120229

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120307

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120418

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120425

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120521

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120612

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120627

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 5031585

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150706

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term